Oncolytics Biotech Insider Trades
NASDAQ: ONCYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 14 · $362.62K
- Sales
- 0 · $0
- Shares bought / sold
- 404.28K / 0
- Net activity
- Net buying $362,615
Oncolytics Biotech insider activity
Over the last 12 months, Oncolytics Biotech insiders reported 14 transactions on SEC Form 4: 14 open-market purchases and 0 sales. Insiders bought $362,615 and sold $0 worth of stock, for net insider buying of $362,615. The most recent filing shows Kelly Jared (Chief Executive Officer) buying 5,050 shares at $0.96 on Mar 12, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ONCY's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ONCY insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 12, 2026 | Kelly JaredChief Executive Officer | Buy | 5,050 | $4.85K | Form 4 |
| Mar 11, 2026 | Parsons James T.Director | Buy | 10,000 | $10.30K | Form 4 |
| Feb 12, 2026 | Seizinger Bernd R.Director | Buy | 40,000 | $33.86K | Form 4 |
| Feb 12, 2026 | Pisano WayneDirector | Buy | 30,000 | $25.34K | Form 4 |
| Feb 12, 2026 | Andrews Patricia SDirector | Buy | 35,400 | $30.29K | Form 4 |
| Feb 12, 2026 | Hagerman AllisonVP, Product Development | Buy | 10,000 | $8.30K | Form 4 |
| Feb 12, 2026 | Brown Deborah MargaretDirector | Buy | 25,000 | $21.24K | Form 4 |
| Feb 12, 2026 | Heineman Thomas CharlesChief Medical Officer | Buy | 12,132 | $10.03K | Form 4 |
| Feb 12, 2026 | Look KirkChief Financial Officer | Buy | 12,000 | $10.10K | Form 4 |
| Feb 12, 2026 | Kelly JaredChief Executive Officer | Buy | 29,500 | $24.84K | Form 4 |
| Feb 11, 2026 | Seizinger Bernd R.Director | Buy | 60,000 | $49.59K | Form 4 |
| Feb 11, 2026 | Aromando AndrewChief Business Officer | Buy | 29,600 | $25.42K | Form 4 |
| Feb 11, 2026 | Kelly JaredChief Executive Officer | Buy | 5,600 | $4.68K | Form 4 |
| Jan 16, 2026 | Seizinger Bernd R.Director | Buy | 100,000 | $103.77K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4